Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865364/0/en/Lexicon-Pharmaceuticals-to-Host-2024-Investor-Day.html
https://www.globenewswire.com/news-release/2024/04/03/2856875/0/en/Lexicon-Pharmaceuticals-to-Participate-in-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/25/2851702/0/en/Clinical-Data-on-the-Impact-of-Sotagliflozin-on-Stroke-and-Heart-Attack-Risk-Among-Four-Lexicon-Sponsored-Presentations-at-the-American-College-of-Cardiology-73rd-Annual-Scientific.html
https://www.fiercepharma.com/pharma/five-years-after-its-first-fda-rejection-lexicon-prepares-resubmit-its-type-1-diabetes
https://www.globenewswire.com//news-release/2024/03/11/2843652/0/en/Lexicon-Pharmaceuticals-Reports-Fourth-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/11/2843641/0/en/Lexicon-Announces-Oversubscribed-250-Million-Private-Placement-of-Equity-Securities.html
https://www.globenewswire.com//news-release/2024/03/11/2843620/0/en/Lexicon-Preparing-to-Resubmit-Sotagliflozin-NDA-for-Type-1-Diabetes-Following-Feedback-From-FDA.html
https://www.globenewswire.com//news-release/2024/01/08/2805278/0/en/Lexicon-Pharmaceuticals-Provides-Business-and-Pipeline-Update-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/12/21/2800348/0/en/Lexicon-Pharmaceuticals-To-Participate-In-The-42nd-Annual-JPMorgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/30/2788490/0/en/Lexicon-Enrolls-First-Patient-in-Phase-2b-Progress-Study-of-LX9211-in-Diabetic-Peripheral-Neuropathic-Pain-DPNP.html